Checkpoint Therapeutics, Inc. revenue breakdown overview

Checkpoint Therapeutics, Inc. revenue for the last year amounted to 103.00 k USD, the most of which — 103.00 k USD — came from its highest performing source at the moment, Novel Treatments for Solid Tumor Cancers, the year earlier bringing 192.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Checkpoint Therapeutics, Inc. 103.00 k USD, and the year before that — 192.00 k USD.